Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Other Working Capital Changes: 2014-2024

Historic Other Working Capital Changes for Protagonist Therapeutics (PTGX) over the last 11 years, with Dec 2024 value amounting to $30.6 million.

  • Protagonist Therapeutics' Other Working Capital Changes rose 34.22% to -$3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.2 million, marking a year-over-year decrease of 153.33%. This contributed to the annual value of $30.6 million for FY2024, which is 1843.70% up from last year.
  • According to the latest figures from FY2024, Protagonist Therapeutics' Other Working Capital Changes is $30.6 million, which was up 1,843.70% from -$1.8 million recorded in FY2023.
  • In the past 5 years, Protagonist Therapeutics' Other Working Capital Changes registered a high of $30.6 million during FY2024, and its lowest value of -$27.1 million during FY2020.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$1.8 million (2023), whereas its average is $8.4 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first crashed by 181.22% in 2020, then spiked by 1,843.70% in 2024.
  • Protagonist Therapeutics' Other Working Capital Changes (Yearly) stood at -$27.1 million in 2020, then spiked by 52.40% to -$12.9 million in 2021, then spiked by 70.84% to -$3.8 million in 2022, then surged by 53.30% to -$1.8 million in 2023, then surged by 1,843.70% to $30.6 million in 2024.